Cervical cancer drugs are used to treat cervical cancer, a type of cancer that occurs in the cells of the cervix, the lower part of the uterus that connects to the vagina. Drugs approved to treat cervical cancer include Topotecan Hydrochloride, Pembrolizumab, Mvasi (Bevacizumab), Keytruda (Pembrolizumab), Hycamtin (Topotecan Hydrochloride), Bevacizumab, Bleomycin Sulfate, and Avastin (Bevacizumab). Cervical cancer is one of the most preventable/treatable forms of cancer, as long as it is detected early and managed effectively.
However, the prevalence of cervical cancer is high in the United States, and thus, the demand for cervical cancer drugs is also high in this region. According to the American Cancer Society, in 2021, around 14,480 new cases of invasive cervical cancer will be diagnosed in the U.S., and about 4,290 women will die from cervical cancer. Moreover, according to the same source, chemotherapy drugs, such as carboplatin (Paraplatin), paclitaxel (Taxol), cisplatin (Platinol), gemcitabine (Gemzar), and topotecan (Hycamtin), are commonly used to treat cervical cancer.
Cervical cancer is caused by sexually acquired infection with certain types of human papilloma virus (HPV). Two types of HPV (16 and 18) cause around 70% of cervical cancers and pre-cancerous cervical lesions. Extensive vaccination with the HPV vaccine may reduce the effects of cervical cancer across the world. For the early stages, radiation or surgery combined with chemotherapy may be used. For later stages of cervical cancer, chemo combined with radiation is usually the main treatment. Chemotherapy is often used to treat advanced cervical cancer.
Chemotherapy can be used as a sole treatment for advanced cancer to slow its progression and relieve symptoms (palliative chemotherapy). However, cervical cancer drugs, such as Cisplatin (chemo drug), used to treat cervical cancer can damage the kidneys. Many times the damage is preventable and reversible, but sometimes the damage may be long-lasting.
No comments:
Post a Comment